Clinical validity and utility of genetic risk scores in prostate cancer

Clinical validity and utility of genetic risk scores in prostate cancer

Current issues related to prostate cancer (PCa) clinical care (e.g., over-screening, over-diagnosis, and over-treatment of nonaggressive PCa) call for risk assessment tools that can be combined with family history (FH) to stratify disease risk among men in the general population. Since 2007, genome-...

Full description

Bibliographic Details
Main Authors: Brian T Helfand, James Kearns, Carly Conran, Jianfeng Xu
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Asian Journal of Andrology
Subjects:
genetic risk score; prostate cancer; pyramid model; single nucleotide polymorphisms
Online Access:http://www.ajandrology.com/article.asp?issn=1008-682X;year=2016;volume=18;issue=4;spage=509;epage=514;aulast=Helfand

Internet

http://www.ajandrology.com/article.asp?issn=1008-682X;year=2016;volume=18;issue=4;spage=509;epage=514;aulast=Helfand

Similar Items